What does Dr. Lien De Gendt, anesthesiste do?

Dr. Lien De Gendt, anesthesiste is a specialist medical practice in Jabbeke. Private Limited, started on 9 April 2018, 1 establishment.

What is the address of Dr. Lien De Gendt, anesthesiste?

The registered office of Dr. Lien De Gendt, anesthesiste is located at Flamincka Park 28, 8490 Jabbeke.

Is Dr. Lien De Gendt, anesthesiste still active?

Yes. According to the CBE (16 September 2026) Dr. Lien De Gendt, anesthesiste is active, legal situation “Normale toestand”, started on 9 April 2018.

Is Dr. Lien De Gendt, anesthesiste registered on Peppol?

Yes, Dr. Lien De Gendt, anesthesiste is registered on the Peppol network with ID 0208:0694534648.

What is the enterprise number of Dr. Lien De Gendt, anesthesiste?

The enterprise number of Dr. Lien De Gendt, anesthesiste is BE0694534648.

When was Dr. Lien De Gendt, anesthesiste founded?

Dr. Lien De Gendt, anesthesiste was founded on 9 April 2018.

Who are the directors of Dr. Lien De Gendt, anesthesiste?

According to the 2025 annual accounts, the directors of Dr. Lien De Gendt, anesthesiste are: Lien. De Gendt.

Is Dr. Lien De Gendt, anesthesiste a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 9 April 2018; 4 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did Dr. Lien De Gendt, anesthesiste make in 2025?

Dr. Lien De Gendt, anesthesiste posted a profit after taxes of € 318,824 in financial year 2025.

What is the revenue of Dr. Lien De Gendt, anesthesiste?

As a small company, Dr. Lien De Gendt, anesthesiste is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 500,818.

Dr. Lien De Gendt, anesthesiste (Private Limited)

Dossier Dr. Lien De Gendt, anesthesiste, printed on 16 September 2026 from databakkes.be/en/0694534648/dr-lien-de-gendt-anesthesiste. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

Dr. Lien De Gendt, anesthesiste from Jabbeke, company number BE0694534648, closed financial year 2025 with a result of € 318,824 after tax. For that financial year Dr. Lien De Gendt, anesthesiste recorded a gross margin of € 500,818 and equity of € 984,868. Compared with financial year 2024, the result moved from € 152,654 to € 318,824. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on October 23, 2025.

What it is worth Growing

€ 984,868

▲ 37% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 318,824

▲ 109% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 218,940

▲ 26% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 53,526 paid out

17 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Vehicles and equipment

€ 65,776

▲ € 49,974 vs 2024

Of which on lease € 63,134.

Debts at end 2025

Bank debt ≈ 4 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 165,955

▲ 25% vs 2024

€ 43,156 is repaid this year. At this pace the long-term loan is gone in ≈ 4 years.

Owed to suppliers

€ 9,708

▼ 12% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 53,715

▲ 245% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 266,104 Gross margin 2022: € 266,104 First fiscal year in the series	€ 292,121 Gross margin 2023: € 292,121 ▲ 10% vs 2022 (€ 266,104) Favourable step	€ 257,598 Gross margin 2024: € 257,598 ▼ 12% vs 2023 (€ 292,121) Unfavourable step	€ 500,818 Gross margin 2025: € 500,818 ▲ 94% vs 2024 (€ 257,598) Favourable step	▲ 94%
Profit after taxes	€ 153,382 Profit after taxes 2022: € 153,382 First fiscal year in the series	€ 175,633 Profit after taxes 2023: € 175,633 ▲ 15% vs 2022 (€ 153,382) Favourable step	€ 152,654 Profit after taxes 2024: € 152,654 ▼ 13% vs 2023 (€ 175,633) Unfavourable step	€ 318,824 Profit after taxes 2025: € 318,824 ▲ 109% vs 2024 (€ 152,654) Favourable step	▲ 109%
Equity	€ 394,483 Equity 2022: € 394,483 First fiscal year in the series	€ 568,516 Equity 2023: € 568,516 ▲ 44% vs 2022 (€ 394,483) Favourable step	€ 719,570 Equity 2024: € 719,570 ▲ 27% vs 2023 (€ 568,516) Favourable step	€ 984,868 Equity 2025: € 984,868 ▲ 37% vs 2024 (€ 719,570) Favourable step	▲ 37%
Total debts	€ 285,249 Total debts 2022: € 285,249 First fiscal year in the series	€ 245,813 Total debts 2023: € 245,813 ▼ 14% vs 2022 (€ 285,249) Favourable step	€ 161,170 Total debts 2024: € 161,170 ▼ 34% vs 2023 (€ 245,813) Favourable step	€ 230,544 Total debts 2025: € 230,544 ▲ 43% vs 2024 (€ 161,170) Unfavourable step	▲ 43%
Cash	€ 166,251 Cash 2022: € 166,251 First fiscal year in the series	€ 219,315 Cash 2023: € 219,315 ▲ 32% vs 2022 (€ 166,251) Favourable step	€ 173,538 Cash 2024: € 173,538 ▼ 21% vs 2023 (€ 219,315) Unfavourable step	€ 218,940 Cash 2025: € 218,940 ▲ 26% vs 2024 (€ 173,538) Favourable step	▲ 26%
Retained profit	€ 375,883 Retained profit 2022: € 375,883 First fiscal year in the series	€ 549,916 Retained profit 2023: € 549,916 ▲ 46% vs 2022 (€ 375,883) Favourable step	€ 700,970 Retained profit 2024: € 700,970 ▲ 27% vs 2023 (€ 549,916) Favourable step	€ 966,268 Retained profit 2025: € 966,268 ▲ 38% vs 2024 (€ 700,970) Favourable step	▲ 38%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 1,600 Dividend 2023: € 1,600 Unchanged (€ 0) Unchanged	€ 1,600 Dividend 2024: € 1,600 Unchanged (€ 1,600) Unchanged	€ 53,526 Dividend 2025: € 53,526 ▲ € 51,926 vs 2024 (€ 1,600) Unchanged	▲ € 51,926
Bank debt	€ 227,381 Bank debt 2022: € 227,381 First fiscal year in the series	€ 179,251 Bank debt 2023: € 179,251 ▼ 21% vs 2022 (€ 227,381) Favourable step	€ 132,500 Bank debt 2024: € 132,500 ▼ 26% vs 2023 (€ 179,251) Favourable step	€ 165,955 Bank debt 2025: € 165,955 ▲ 25% vs 2024 (€ 132,500) Unfavourable step	▲ 25%
Balance sheet total	€ 679,732 Balance sheet total 2022: € 679,732 First fiscal year in the series	€ 814,329 Balance sheet total 2023: € 814,329 ▲ 20% vs 2022 (€ 679,732) Unchanged	€ 880,740 Balance sheet total 2024: € 880,740 ▲ 8% vs 2023 (€ 814,329) Unchanged	€ 1,215,411 Balance sheet total 2025: € 1,215,411 ▲ 38% vs 2024 (€ 880,740) Unchanged	▲ 38%

Key figures of Dr. Lien De Gendt, anesthesiste, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 October 2026.

What happened to Dr. Lien De Gendt, anesthesiste?

What happened at Dr. Lien De Gendt, anesthesiste in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Oct 23, 2025 New annual accounts for financial year 2025: profit of € 318,824 (▲ 109% vs 2024). Source: NBB ↗
2023 Lien. De Gendt became a director. NBB
Apr 9, 2018 New establishment in Torhout. KBO
Apr 9, 2018 Start of the company according to the CBE. KBO

In short

From € 153,382 profit in 2022 to € 318,824 profit in 2025.

Paid € 344,953 in corporate taxes since 2022.

Best year ever: 2025, with € 318,824 profit.

Paid out € 56,726 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at Dr. Lien De Gendt, anesthesiste? We notify you, reason included.

Follow Dr. Lien De Gendt, anesthesiste

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Lien. De Gendt

Dr. Lien De Gendt, anesthesiste

Behind Dr. Lien De Gendt, anesthesiste is Lien. De Gendt.

See the full network in the app

Directors

According to the 2025 annual accounts

Lien. De Gendt

Director

since 2023

Establishments

Establishment units

Physical locations of this company

Registered office

Flamincka Park 28

8490 Jabbeke

2.275.662.065

Sint-Rembertlaan 21

8820 Torhout

Active since 9 April 2018

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0694.534.648
VAT number: BE 0694.534.648
Registered office: Flamincka Park 28, 8490 Jabbeke
Names & denominations: Dr. Lien De Gendt, anesthesiste
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 9 April 2018
Peppol: Active · Active since 10 Dec 2025
Activities · NACE: Activiteiten van medisch specialisten

View on CBE Public ↗ Annual accounts (NBB) ↗